SecBot SecBot
SECBOTREPLAY Home › Report › REGN

REGN · Director George L

REGENERON PHARMACEUTICALS, INC. · 144 filed Nov 2, 2026 at 16:13 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 2, 2026 at 16:13 ET

Director George L. Sing filed a Form 144 notice of intent to sell 21,129 shares of Regeneron common stock, with an approximate market value of $20.4 million based on the filing. The shares to be sold were acquired through option exercises, some recent and some previously exercised. This is a routine insider sale filing by a director and does not indicate a change in company fundamentals.

  • George L. Sing, a director of Regeneron, filed a Form 144 on November 2, 2026.
  • The filing covers the proposed sale of 21,129 shares of common stock.
  • The approximate market value of the proposed sale is $20,376,359.76.
  • The shares were acquired through exercise of options under a registered plan and previously exercised options.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access